Contrast-induced nephropathy in the critically ill patients;Néphropathie induite par les produits de contraste iodés en réanimation

Reanimation

Volumn 21, Issue 4, 2012, Pages 463-473

  Ehrmann, S ^a,b,c   Pajot, O ^d   Lakhal, K ^e  

^a HENRI MONDOR HOSPITAL   (France)

^b INSERM U955   (France)

^c UNIVERSITY HOSPITAL OF TOURS   (France)

^d CENTRE HOSPITALIER VICTOR DUPOUY   (France)

^e LAPEYRONIE HOSPITAL   (France)

Author keywords

Acute kidney injury; Angiography; Intensive care unit; N acetylcystein; Sodium bicarbonate; Tomography; X ray computed

Indexed keywords

CONTRAST MEDIUM;

ACUTE KIDNEY FAILURE; CLINICAL ASSESSMENT; CONTRAST INDUCED NEPHROPATHY; CRITICALLY ILL PATIENT; EMERGENCY CARE; HUMAN; HYPOVOLEMIA; INTENSIVE CARE UNIT; KIDNEY FUNCTION; OUTCOME ASSESSMENT; PROGNOSIS; REVIEW; RISK FACTOR;

EID: 84863941305     PISSN: 16240693     EISSN: 19516959     Source Type: Journal    
DOI: 10.1007/s13546-011-0434-9     Document Type: Review

References (65)

1. McCullough PA (2008) Acute kidney injury with iodinated contrast. Crit Care Med 36:S204-S11
2. Persson PB, Hansell P, Liss P (2005) Pathophysiology of contrast medium-induced nephropathy. Kidney Int 68:14-22
3. Brochard L, Abroug F, Brenner M, et al (2010) An Official ATS/ERS/ESICM/SCCM/SRLF Statement: prevention and management of acute renal failure in the ICU patient: an international consensus conference in intensive care medicine. Am J Respir Crit Care Med 181:1128-55
4. Uchino S, Kellum JA, Bellomo R, et al (2005) Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294:813-8
5. Hall EJ, Brenner DJ (2008) Cancer risks from diagnostic radiology. Br J Radiol 81:362-78
6. Haveman JW, Gansevoort RT, Bongaerts AH, Nijsten MW (2006) Low incidence of nephropathy in surgical ICU patients receiving intravenous contrast: a retrospective analysis. Intensive Care Med 32:1199-205
7. Huber W, Eckel F, Hennig M, et al (2006) Prophylaxis of contrast material-induced nephropathy in patients in intensive care: acetyl-cysteine, theophylline, or both? A randomized study. Radiology 239:793-804
8. Huber W, Jeschke B, Page M, et al (2001) Reduced incidence of radiocontrast-induced nephropathy in ICU patients under theo-phylline prophylaxis: a prospective comparison to series of patients at similar risk. Intensive Care Med 27:1200-9
9. Lakhal K, Ehrmann S, Chaari A et al (2011) Acute Kidney Injury Network definition of contrast-induced nephropathy in the critically ill: Incidence and outcome. J Crit Care 26:593-9
10. Ng CS, Shaw AD, Bell CS, Samuels JA (2010) Effect of IV contrast medium on renal function in oncologic patients undergoing CT in ICU. AJR Am J Roentgenol 195:414-22
11. Polena S, Yang S, Alam R, et al (2005) Nephropathy in critically Ill patients without preexisting renal disease. Proc West Pharmacol Soc 48:134-5
12. Rashid AH, Brieva JL, Stokes B (2009) Incidence of contrast-induced nephropathy in intensive care patients undergoing computerised tomography and prevalence of risk factors. Anaesth Intensive Care 37:968-75
13. Burns KE, Priestap F, Martin C (2010) N-acetylcysteine in critically ill patients undergoing contrast-enhanced computed tomography: a randomized trial. Clin Nephrol 74:323-6
14. Matsushima K, Peng M, Schaefer EW, et al (2011) Posttraumatic contrast-induced acute kidney injury: minimal consequences or significant threat? J Trauma 70:415-9; discussion 9-20
15. McGillicuddy EA, Schuster KM, Kaplan LJ, et al (2011) Contrast-induced nephropathy in elderly trauma patients. J Trauma 68:294-7
16. Mehran R, Nikolsky E (2006) Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl S11-S5
17. Pannu N, Wiebe N, Tonelli M, Alberta Kidney Disease Network (2006) Prophylaxis strategies for contrast-induced nephropathy. JAMA 295:2765-79
18. Rosca MG, Mustata TG, Kinter MT, et al (2005) Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation. Am J Physiol Renal Physiol 289:F420-F30
19. Trivedi HS, Moore H, Nasr S, et al (2003) A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Practice 93:C29-C34
20. Mueller C, Buerkle G, Buettner HJ, et al (2002) Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 162:329-36
21. Solomon R, Werner C, Mann D, D'Elia J, Silva P (1994) Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 331:1416-20
22. Kim KS, Kim K, Hwang SS, et al (2011) Risk stratification nomogram for nephropathy after abdominal contrast-enhanced computed tomography. Am J Emerg Med 29:412-7
23. Mehran R, Aymong ED, Nikolsky E, et al (2004) A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44:1393-9
24. Barrett BJ, Carlisle EJ (1993) Metaanalysis of the relative nephrotoxicity of high-and low-osmolality iodinated contrast media. Radiology 188:171-8
25. Mehta RL, Kellum JA, Shah SV, et al (2007) Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31
26. Cruz DN, Ricci Z, Ronco C (2009) Clinical review: RIFLE and AKIN-time for reappraisal. Crit Care 13:211
27. Tillyard A, Keays R, Soni N (2005) The diagnosis of acute renal failure in intensive care: mongrel or pedigree? Anaesthesia 60:903-14
28. Malyszko J (2010) Biomarkers of acute kidney injury in different clinical settings: a time to change the paradigm? Kidney Blood Press Res 33:368-82
29. Shaker OG, El-Shehaby A, El-Khatib M (2010) Early diagnostic markers for contrast nephropathy in patients undergoing coronary angiography. Angiology 61:731-6
30. Briguori C, Visconti G, Rivera NV, et al (2011) Cystatin C and contrast-induced acute kidney injury. Circulation 121:2117-22
31. Malyszko J, Bachorzewska-Gajewska H, Poniatowski B, et al (2009) Urinary and serum biomarkers after cardiac catheteriza-tion in diabetic patients with stable angina and without severe chronic kidney disease. Ren Fail 31:910-9
32. Ling W, Zhaohui N, Ben H, et al (2008) Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography. Nephron Clin Pract 108:c176-c81
33. Bagshaw SM, Bennett M, Haase M, et al (2010) Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness. Intensive Care Med 36:452-61
34. Martensson J, Bell M, Oldner A, et al (2010) Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury. Intensive Care Med 36:1333-40
35. Levy EM, Viscoli CM, Horwitz RI (1996) The effect of acute renal failure on mortality. A cohort analysis. JAMA 275:1489-94
36. Chertow GM, Burdick E, Honour M, et al (2005) Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16:3365-70
37. Nin N, Lombardi R, Frutos-Vivar F, et al (2010) Early and small changes in serum creatinine concentrations are associated with mortality in mechanically ventilated patients. Shock 34:109-16
38. Lassnigg A, Schmidlin D, Mouhieddine M, et al (2004) Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 15:1597-605
39. Stacul F, van der Molen AJ, Reimer P, et al (2011) Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 21:2527-41
40. Meschi M, Detrenis S, Musini S, et al (2006) Facts and fallacies concerning the prevention of contrast medium-induced nephropa-thy. Crit Care Med 34:2060-8
41. McCullough PA, Bertrand ME, Brinker JA, Stacul F (2006) A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. J Am Coll Cardiol 48:692-9
42. Solomon R (2005) The role of osmolality in the incidence of contrast-induced nephropathy: a systematic review of angiogra-phic contrast media in high risk patients. Kidney Int 68:2256-63
43. Laskey WK, Jenkins C, Selzer F, et al (2007) Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. J Am Coll Cardiol 50:584-90
44. Morcos SK (2004) Prevention of contrast media nephrotoxicity-the story so far. Clin Radiol 59:381-9
45. Abujudeh HH, Gee MS, Kaewlai R (2009) In emergency situations, should serum creatinine be checked in all patients before performing second contrast CT examinations within 24 hours? J Am Coll Radiol 6:268-73
46. Katzberg RW, Morris TW, Schulman G, et al (1983) Reactions to intravenous contrast media. Part II: acute renal response in euvo-lemic and dehydrated dogs. Radiology 147:331-4
47. Merten GJ, Burgess WP, Gray LV, et al (2004) Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 291:2328-34
48. Maioli M, Toso A, Leoncini M, et al (2008) Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiogra-phy or intervention. J Am Coll Cardiol 52:599-604
49. Briguori C, Airoldi F, D'Andrea D, et al (2007) Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation 115:1211-7
50. Recio-Mayoral A, Chaparro M, Prado B, et al (2007) The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study. J Am Coll Cardiol 49:1283-8
51. Tepel M, van der Giet M, Schwarzfeld C, et al (2000) Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343:180-4
52. Marenzi G, Assanelli E, Marana I, et al (2006) N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 354:2773-82
53. Baker CS, Wragg A, Kumar S, et al (2003) A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study. J Am Coll Cardiol 41:2114-8
54. Briguori C, Colombo A, Violante A, et al (2004) Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity. Eur Heart J 25:206-11
55. Kay J, Chow WH, Chan TM, et al (2003) Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. JAMA 289:553-8
56. Hoffmann U, Fischereder M, Kruger B, et al (2004) The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol 15:407-10
57. Briguori C, Manganelli F, Scarpato P, et al (2002) Acetylcysteine and contrast agent-associated nephrotoxicity. J Am Coll Cardiol 40:298-303
58. ACTinvestigators (2011) Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT). Circulation 124:1250-9
59. Zhang T, Shen LH, Hu LH, He B (2011) Statins for the prevention of contrast-induced nephropathy: a systematic review and meta-analysis. Am J Nephrol 33:344-51
60. Spargias K, Alexopoulos E, Kyrzopoulos S, et al (2004) Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 110:2837-42
61. Marenzi G, Lauri G, Campodonico J, et al (2006) Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients. Am J Med 119:155-62
62. Marenzi G, Marana I, Lauri G, et al (2003) The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med 349:1333-40
63. Bentley ML, Corwin HL, Dasta J (2010) Drug-induced acute kidney injury in the critically ill adult: recognition and prevention strategies. Crit Care Med 38:S169-S74
64. Kulvatunyou N, Rhee PM, Carter SN, et al (2011) Defining incidence and outcome of contrast-induced nephropathy among trauma: is it overhyped? Am Surg 77:686-9
65. Hipp A, Desai S, Lopez C, Sinert R (2008) The incidence of contrast-induced nephropathy in trauma patients. Eur J Emerg Med 15:134-9